Co-Diagnostics, Inc. (CODX) › Cash & EquivalentsCo-Diagnostics, Inc. (CODX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2015: $33.8K2016: $998.7K2017: $3.53M2018: $950.2K2019: $893.1K2020: $42.98M2021: $88.61M2022: $22.97M2023: $14.92M2024: $2.94M2025: $11.88M$11.88M2015Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$11.88M+304.7%2024$2.94M-80.3%2023$14.92M-35.1%2022$22.97M-74.1%2021$88.61M+106.2%2020$42.98M+4711.9%2019$893.1K-6.0%2018$950.2K-73.1%2017$3.53M+253.9%2016$998.7K+2854.4%2015$33.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share